ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 171 filers reported holding ASCENDIS PHARMA A/S in Q2 2022. The put-call ratio across all filers is 0.47 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $932,000 | -65.8% | 7,939 | -61.6% | 0.01% | -26.7% |
| Q2 2021 | $2,723,000 | +171.5% | 20,699 | +218.4% | 0.02% | +25.0% |
| Q3 2020 | $1,003,000 | +1.4% | 6,500 | -2.8% | 0.01% | +9.1% |
| Q2 2020 | $989,000 | -21.9% | 6,690 | -26.5% | 0.01% | +10.0% |
| Q4 2019 | $1,266,000 | +227.1% | 9,100 | +126.3% | 0.01% | +233.3% |
| Q3 2019 | $387,000 | -79.3% | 4,022 | -75.2% | 0.00% | -83.3% |
| Q2 2019 | $1,869,000 | -15.1% | 16,232 | -70.5% | 0.02% | +63.6% |
| Q4 2017 | $2,201,000 | -78.6% | 54,952 | -80.6% | 0.01% | -75.6% |
| Q3 2017 | $10,271,000 | +509.9% | 283,330 | +240.5% | 0.04% | +181.2% |
| Q4 2016 | $1,684,000 | – | 83,200 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 5,865,338 | $978,221,000 | 13.68% |
| Vivo Capital, LLC | 1,797,745 | $299,828,000 | 13.38% |
| Sofinnova Investments, Inc. | 1,109,874 | $185,105,000 | 11.02% |
| Avoro Capital Advisors LLC | 1,800,000 | $300,204,000 | 5.17% |
| Eventide Asset Management | 1,704,148 | $284,218,000 | 4.36% |
| Stenahm Asset Managment Ltd | 29,000 | $4,837,000 | 4.07% |
| Ghost Tree Capital, LLC | 105,000 | $17,512,000 | 3.90% |
| Eversept Partners, LP | 187,043 | $31,195,032 | 3.66% |
| Spyglass Capital Management LLC | 701,594 | $117,012,000 | 3.59% |
| Q Global Advisors, LLC | 23,183 | $3,866,000 | 2.72% |